CCDC164 Activators
Chemical activators of CCDC164 can influence the protein's activity through various cellular signaling pathways and molecular mechanisms. Forskolin, for example, can directly stimulate adenylate cyclase, which increases intracellular cAMP levels. The rise in cAMP can activate protein kinase A (PKA), which in turn can phosphorylate CCDC164, leading to its activation. Ionomycin, by raising intracellular calcium levels, can activate calcium-dependent protein kinases such as calmodulin-dependent kinase (CaMK), which can also phosphorylate CCDC164, resulting in its activation. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is known for phosphorylating a variety of protein substrates, possibly including CCDC164. This direct phosphorylation by PKC can function as an activation mechanism for CCDC164.
Inhibitors of protein phosphatases, such as Calyculin A and Okadaic Acid, can indirectly maintain CCDC164 in an activated state by preventing its dephosphorylation, ensuring that it remains phosphorylated and active. Anisomycin, which activates stress-activated protein kinases including JNK and p38 MAP kinase, can phosphorylate CCDC164 as part of the cellular stress response, thereby activating it. Epidermal Growth Factor (EGF) stimulates the MAPK/ERK pathway, leading to the activation and phosphorylation of various proteins, which may include CCDC164. S-Nitroso-N-acetylpenicillamine (SNAP) can release nitric oxide that activates guanylate cyclase, which raises cGMP levels, potentially activating kinases that phosphorylate CCDC164. BAY 11-7082's inhibition of the NF-κB pathway could alter phosphorylation patterns within the cell, inadvertently leading to CCDC164's activation. Dibutyryl-cAMP (db-cAMP) is a permeable analog of cAMP that can activate PKA and may phosphorylate CCDC164. Ouabain inhibits the Na+/K+ ATPase, which can increase intracellular calcium and potentially activate CaMK, leading to the phosphorylation and activation of CCDC164. Lastly, insulin initiates the PI3K/AKT signaling pathway, which is involved in a series of phosphorylation events that can lead to the activation of CCDC164.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, this can activate calcium-dependent protein kinases, such as calmodulin-dependent kinase (CaMK), which may phosphorylate CCDC164, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide array of substrates, potentially including CCDC164, thereby directly leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins. By inhibiting the dephosphorylation, CCDC164 remains phosphorylated and hence activated. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid is a potent inhibitor of protein phosphatases. By preventing dephosphorylation, it indirectly maintains CCDC164 in an activated, phosphorylated state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK and p38 MAP kinase. These kinases can phosphorylate and activate CCDC164 as part of the cellular stress response. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
SNAP releases nitric oxide, which activates guanylate cyclase, leading to increased levels of cGMP. This could activate protein kinases that phosphorylate and thereby activate CCDC164. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is known to inhibit the NF-κB pathway. Inhibition of this pathway can alter the phosphorylation status of various proteins, potentially leading to the activation of CCDC164 through altered cellular signaling dynamics. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Db-cAMP is a cAMP analog that diffuses into cells and activates PKA. Activated PKA can lead to the phosphorylation and activation of CCDC164. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+ ATPase, which can lead to increased intracellular calcium levels and the subsequent activation of CaMK, possibly resulting in the phosphorylation and activation of CCDC164. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin triggers the PI3K/AKT signaling pathway, which can lead to a cascade of phosphorylation events that potentially include the activation of CCDC164. | ||||||